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a b s t r a c t
Equine herpesvirus type 1 (EHV-1) ORF59 is predicted to encode a protein consisting of 180 amino acids.
To determine whether ORF59 in fact encodes a protein, sequences encoding an HA epitope (YPYDVPDYA)
was inserted at the carboxyterminus of the ORF59 protein in EHV-1 strain Ab4. Using anti-HA
monoclonal antibodies, a 21-kDa band was speciﬁcally detected by western blot analysis in lysates of
cells infected with a recombinant EHV-1 from strain Ab4 that carries the pORF59-HA but not in cells
infected with parental Ab4. Further characterization of the protein using immunoﬂuorescence and
fractionation studies showed that pORF59 is an early protein that localizes to the cytosol in virus-infected
cells. Recombinant EHV-1 lacking ORF59 (rAb4Δ59) exhibited a small-plaque phenotype and could not
be propagated. Our ﬁndings suggest that the ORF59 protein plays a major role in EHV-1 replication
in vitro and likely in vivo.
Crown Copyright & 2013 Published by Elsevier Inc. All rights reserved.
Equine herpesvirus type 1 (EHV-1) is a member of the sub-
family Alphaherpesvirinae and the genus Varicellovirus in the
Alloherpesviridae family (Davison et al., 2009). EHV-1 is one of
the most important causes of respiratory disease in horses and can
also cause abortion and nervous manifestations with frequently
fatal outcome (Brosnahan et al., 2009; Ma et al., 2013; Rosas et al.,
2006). The complete genome sequence of the double-stranded
EHV-1 DNA genome was reported (Telford et al., 1992). It is
approximately 150-kbp in length and contains 80 open reading
frames (ORFs), of which 76 are unique. Six genes are duplicated in
the terminal repeat sequence (Davison et al., 2009; Telford et al.,
1992). Comparison of the sequences of EHV-1 and the human
pathogens herpes simplex virus type 1 (HSV-1) and varicella zoster
virus (VZV) revealed that most of the genes are conserved between
the viruses. Among the predicted genes in Ab4 strain of EHV-1,
however, we ﬁnd six genes, ORFs l, 2, 3, 34, 59 and 67, which lack
positional and/or sequence homologs in HSV-1 (Telford et al., 1992).
One of the six genes, ORF59, is predicted to encode a protein of 180
amino acids in length (Telford et al., 1992). Although EHV-1 ORF59
does not have a homolog in HSV-1, it does share positional and
limited sequence homology with proteins encoded by other mem-
bers of the Varicellovirus genus. The putative homologs of EHV-1
ORF59 are VZV gene 57 (Cox et al., 1998) and equine herpesvirus type
4 (EHV-4) gene 59 (Telford et al., 1998) as well as the UL3.5 genes of
pseudorabies virus (PRV) (Dean and Cheung, 1993), bovine herpes-
virus type 1 (BHV-1) (Khattar et al., 1995), and infectious laryngo-
tracheitis virus (Fuchs and Mettenleiter, 1996).
The predicted amino acid sequence of EHV-1 pORF59 was aligned
by CLUSTAL to its orthologues of EHV-4 (pORF59), BHV-1 (pUL3.5),
PRV (pUL3.5) and VZV (pORF57). Overall amino acid identities are
highest to the EHV-4 orthologue, although there is quite a discre-
pancy in length and the amino acid identity (48%) at the lower end of
the spectrum of amino acid similarities between proteins of the two
closely related viruses (Fig. 1). The VZV ORF57 gene is predicted to
encode a protein of only 71 amino acids, its product is localized in the
cytosol of VZV-infected cells and was shown to not play a major role
in VZV replication in cultured cells (Cox et al., 1998). Identiﬁcation
and characterization of the homolog in PRV, showed that pUL3.5 is a
224 amino acid protein that is critical for virus growth in cell culture,
more speciﬁcally virus egress after secondary envelopment (Fuchs
and Mettenleiter, 1996). The BHV-1 UL3.5 protein was characterized
by Schikora et al. (1998) who reported that the 126 amino acid
protein has an apparent size of 13.2 kDa, is expressed late in
infection, and localizes to the cytoplasm but not the nucleus of
BHV-1-infected cells.
As there is no information on the function of the protein
encoded by EHV-1 ORF59 (pORF59), we aimed at verifying that
it is indeed expressed in EHV-1-infected cells. As there was no
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protein-speciﬁc antibody available, we used epitope insertion to
show that ORF59 is expressed with early kinetics and that its
product is localized to the cytosol of infected cells. We also
investigated whether pORF59 has a role in virus replication and
generated an EHV-1 Ab4 mutant with a deletion of ORF59.
Analysis of the mutant demonstrated that that EHV-1 ORF59
protein is essential for virus replication in cell culture.
To achieve the goals of the study, we ﬁrst generated an EHV-1
recombinant virus lacking ORF59 (Ab4Δ59) and a recombinant
with an HA-tagged ORF59 protein (rAb4_59-HA). Mutant viruses
were based on wild-type strain Ab4, which had previously been
cloned as an infectious bacterial artiﬁcial chromosome (BAC)
clone, pAb4, in which mini-F vector sequences along with an
eGFP marker was inserted into the viral genome instead of
gp2-encoding gene 71 (Goodman et al., 2007). Rabbit kidney
(RK13) cells were propagated in modiﬁed Eagle's medium
(MEM) (Biochrom) supplemented with 5% fetal bovine serum
(FBS, Biochrom), 100 U/ml penicillin, and 100 μg/ml streptomycin
(1% penicillin–streptomycin). Equine dermal (NBL-6) cells were
grown in Iscove’s modiﬁed Dulbecco's medium (IMDM; Invitro-
gen) supplemented with 20% FBS. The anti-HA tag (6E2) mouse
monoclonal antibody (MAb) and rabbit anti-β-actin polyclonal
antibody (pAb) were purchased from Cell Signaling Technologies.
Mouse anti-EHV-1 gM mab F6 has been previously described
(Ma et al., 2012; Rudolph and Osterrieder, 2002; Said et al.,
2012). Horseradish peroxidase-conjugated goat anti-rabbit and
goat anti-mouse antibodies were obtained from Southern Biotech,
Alexa Fluor 568-conjugated goat anti-mouse from Invitrogen.
Wild-type recombinant (r)Ab4 and mutant (rAb4Δ59 and
rAb4_59-HA) viruses were obtained after transfection of BAC
DNA into RK13 cells. Transfection was performed exactly as
previously described (Rudolph et al., 2002).
To construct pcDNA3 with the HA sequence tag inserted at the
carboxyterminus of ORF59 (pcDNA_59-HA), the ORF59 gene was
ampliﬁed by PCR with a tag from Ab4 strain of EHV-1 using
primers P1 and P2 (Table 1). The EHV-1 ORF59 gene was also
Fig. 1. Alignment of the EHV-1 pORF59 amino acid sequence with those of its orthologues of related varicelloviruses. The amino acid sequences were aligned using CLUSTAL
(http://bioinformatics.org/sms/) to EHV-4 pORF59, BHV-1 pUL3.5, PRV pUL3.5 and VZV pORF57. Identical amino acids are shown in black boxes. Overall amino acid identities
between EHV-1 pORF59 and the related proteins were 48.4 (EHV-4), 30.3 (BHV-1), 26 (PRV) and 12.2% (VZV), respectively.
Table 1
Oligonucleotides used in this study.
Primer Product Sequence 5′–3′
Plasmid
P1 ORF59þHA attggatccgccaccatggacgtgtttgggcgaggac
P2 in pcDNA3 accgaattcttaagcgtaatctggaacatcg
P3 ORF59 in attggtaccatggacgtgtttgggcgaggac
P4 pcDNA3 attgcggccgcaaacacgctcaggcacatgtaa
P5 tcggaattcatggacgtgtttgggcgaggacaggatgacgacgataagtaggg
P6 Kan caagaattcaaacacgctcaggcacatgtaacaaccaattaaccaattctgattag
Sequencing
P7 atggacgtgtttgggcgaggac
P8 ttaagcgtaatctggaacatcg
P9 Sequencing atggacgtgtttgggcgaggac
P10 aaacacgctcaggcacatgtaa
Mutagenesis
P11 ORF59 deletion taacgtttatttggtttttattgattgcttggcgggttttcctacgcaaggacggtggttaggatgacgacgataagtaggg
P12 ctctctatccgatacaaaccaaccaccgtccttgcgtaggaaaacccgccaagcaatcaacaaccaattaaccaattctgattag
P13 HA tag cgtttatttggtttttattgattgcttggcgggttttttaagcgtaatctggaacatcgtatgggtacatgtgcctgagcaggatgacgacgataagtaggg
P14 insertion gggacgaccgaggccgagaagaaacacgctcaggcacatgtacccatacgatgttccagattacgcttaaaaaacccgcccaaccaattaaccaattctgattag
Revertant
P15 ORF59þKan taaacgtttatttggtttttattgattgcttggcgggttttttacatgtgcctgagcgtgtcctcg
P16 cccaaacacgtccatcctacgcaaggacggtggttggtttgtatcggatagagag
Restriction enzyme sites are given in lower case bold letters; sequences in italics indicate additional bases, which are not present in the EHV-1 sequence.
Underlined sequences indicate the template-binding region of the primers for PCR ampliﬁcation with pEPkan-s.
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ampliﬁed by PCR without a tag using primers P3 and P4 (Table 1).
The PCR products were digested with appropriate restriction
enzymes and inserted into pcDNA3 (Invitrogen) resulting in the
recombinant plasmids pcDNA_59-HA and pcDNA-59. To generate
recombinant plasmid pcDNA_59 with a kanamycin resistance
(kanR), the aphAI gene was ampliﬁed from plasmid pEPkan-S by
PCR using primers P5 and P6 (Table 1). The PCR products were
digested with the appropriate restriction enzymes and inserted
into pcDNA_59. Correct ampliﬁcation and insertion were con-
ﬁrmed by nucleotide sequencing (Starseq) using primers P7, P8,
P9 and P10, respectively (Table 1).
For genetic manipulation, GS1783 cells containing pAb4 were
maintained in Luria-Bertani (LB) medium containing 30 mg/ml
chloramphenicol. Deletion of ORF59 gene was done via two-step
Red recombination as previously described (Tischer et al., 2006).
Brieﬂy, PCR primers P11 and P12 (Table 1) were designed to have
recombination arms of 60 nucleotides that enabled the substitu-
tion of the ORF59 gene by the aphAI (kanR) gene at nucleotide 1–
540 in EHV-1 Ab4 strain. PCR products were digested with DpnI in
order to remove residual template DNA. Transfer fragments were
then electroporated into GS1783 containing the BAC. Kanamycin-
resistant colonies were isolated and screened by PCR and restric-
tion fragment length polymorphism (RFLP) to detect E. coli cells
harboring mutant BAC DNA. Positive clones were subjected to a
second round of Red recombination to obtain the ﬁnal constructs,
pAb4Δ59, after excision of the kanR gene. Using the same strategy,
pAb4 with HA tag sequences fused to the carboxyterminus of
ORF59 (pAb4_59-HA) was constructed. We designed primers P13
and P14 (Table 1) with recombination arms of 100 nucleotides that
enabled the insertion of the HA tag sequences at the desired
position following ampliﬁcation of the aphAI gene ampliﬁed from
plasmid pEPKan-S. The revertant pAb4Δ59R, in which the original
sequences were restored, was constructed using the same meth-
odology. Brieﬂy, pcDNA_59 containing the aphAI gene was ampli-
ﬁed by PCR using primers P15 and P16 (Table 1). The primers were
designed to have recombination arms that enabled the insertion of
the product at nucleotide of 105,877 in EHV-1 Ab4 sequences
(Tischer et al., 2006). PCR, RFLP, and nucleotide sequencing using
primers P7–P10 (Table 1) conﬁrmed the genotypes of the all
mutant and revertant clones.
Mutant BAC DNA from colonies after ﬁrst and second round of
Red recombination were extracted, and checked by RFLP analysis
after digestion with HindIII. DNA fragments were separated by 0.8%
agarose gel electrophoresis and stained with ethidium bromide to
examine restriction enzyme patterns (Fig. 2). PCR was used to
further verify the insertion and excision of aphAI in the recombi-
nant pAb4Δ59 clones (data not shown). PCR analysis indicated
that HA tag sequences in pAb4_59-HA were correctly inserted,
which was conﬁrmed by RFLP (Fig. 2) and nucleotide sequencing
(data not shown). The appropriate revertant pAb4Δ59R from
pAb4Δ59, in which the deleted sequences were restored, was also
tested using the same strategy (Fig. 2). Reconstitution of parental
rAb4 and mutant viruses were achieved by transfection of 2 μg
BAC DNA into RK13 cells (Rudolph et al., 2002).
To characterize the ORF59 protein product, western blot ana-
lysis was used to detect pORF59 expression as described before
(Osterrieder et al., 1996; Said et al., 2012). RK13 cells were seeded
in 6-well plates and infected either with rAb4, rAb4Δ59 or
rAb4_59-HA. Pellets of infected cells or cells transfected with
pcDNA and pcDNA that contained either ORF59 (pcDNA_59) or
Fig. 2. Generation of EHV-1 lacking ORF59 (rAb4Δ59) or expressing HA-tag at the pORF59 carboxyterminus (rAb4_59-HA): (A) schematic illustration of two-step red
mutagenesis applied in the construction of mutant genomes (rAb4Δ59 and rAb4_59-HA). Schematic representation of the genomic organization and the HindIII restriction
map of (pAb4) are given. The two unique segments (UL and US), and the terminal and internal repeat sequences (TRS and IRS) are shown. (B) Identiﬁcation of pAb4Δ59 by
RFLP. An ethidium bromide-stained agarose gel is shown with HindIII restrictions patterns of pAb4 (lane 1), the cloning intermediate (lane 2), the ﬁnal pAb4Δ59 construct
(lane 3) and pAb4Δ59R (lane 4) and separated by 0.8% agarose gel electrophoresis. (C) Identiﬁcation of pAb4_59-HA by RFLP. Puriﬁed DNA from pAb4 (lane 1), the cloning
intermediate (lane 2) and the ﬁnal construct pAb4_59-HA (lane 3) were digested with HindIII and separated by 0.8% agarose gel electrophoresis. A molecular weight marker
(GeneRuler 1 kb Plus DNA Ladder (Thermo Scientiﬁc)) was used for determination of DNA fragment sizes and was loaded in lane M.
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ORF59 tagged with HA sequences (pcDNA_59-HA) were resuspended
in radioimmunoprecipitation assay (RIPA) buffer [1 mM Tris, pH 7.4;
1% Triton X-100; 0.25% Na-deoxycholate; 5 M sodium chloride;
0.5 mM EDTA; 0.1% sodium dodecyl sulfate (SDS)] and protease
inhibitor cocktail (Roche). Samples were heated at 95 1C for 5 min,
and subjected to SDS–10% polyacrylamide gel electrophoresis (PAGE),
then transferred to a PVDF membrane by using a semi-dry electro-
blotter (Peqlab). Expression of EHV-1 ORF59 protein (pORF59), viral
glycoprotein M (gM) or cellular β-actin was detected with speciﬁc
antibodies and peroxidase conjugates mentioned above. Reactive
bands were visualized by enhanced chemiluminescence (ECL plus,
Amersham).
Fig. 3. Characterization of pORF59 expression in transfected or infected cells: (A) RK13 cells were transfected either with pcDNA, pcDNA_59 or pcDNA_59-HA. In vitro
expression of pORF59 with western blot analysis in cell lysates transfected with pcDNA_59-HA yield a 21-kDa protein but not in those pcDNA and pcDNA_59. Cells were
infected either with parental rAb4 or Ab4Δ59 or rAb4_59-HA virus (B). Cell lysates from infected cells were prepared and subjected to western blot analysis. Anti-HA MAb
was used to detect pORF59 expression in (A) and (B). β-Actin was used as a loading control. Cell lysates were prepared and proteins were separated by SDS–12%-PAGE before
transfer to a PVDF membrane. The PageRulerTM Prestained protein ladder (Thermo Scientiﬁc) was used for determination of protein sizes and was loaded in lane M.
Fig. 4. Identiﬁcation of the pORF59 as an early protein. Detection of the pORF59 expression in EHV-1 infected RK13 cells in the presence or absence of PAA or metabolic
inhibitors: (A) expression of pORF59 was determined for each time point in panel A by western blotting in the presence or absence of PAA. Detection of pORF59 expression
was started at 1 h p.i. with a band of 21 kDa in size and also the same band was detected at 16, and 24 h p.i. in the presence of PAA. Expression of gM and β-actin was
determined as temporal and loading controls, respectively. (B) To differentiate whether pORF59 is an early or immediate early protein, cell lysates frommock-infected cells or
cells infected with rAb4_59HA in the presence or absence of CX/Act-D were harvested and analyzed by immunoblotting. Proteins were extracted from cells infected with
rAb4_59-HA and an anti-HA MAb was used for detection. The PageRulerTM Prestained protein ladder (Thermo Scientiﬁc) was used for determination of protein sizes and
was loaded in lane M.
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The anti-HA antibody speciﬁcally detected a 21-kDa band
corresponding to pORF59 in pcDNA_59-HA-transfected cells
(Fig. 3A) but not in cells transfected with pcDNA or pcDNA_59.
The anti-HA MAb also reacted speciﬁcally with a band of the same
size in rAb4_59-HA-infected cells but not in lysates of Rk13 cells
infected with parental rAb4 or rAb4Δ59 (Fig. 3B). We concluded
from our results that the anti-HA antibody was able to detect a
pORF59-speciﬁc band and did not exhibit any cross-reactivity with
other viral or cellular proteins.
To determine the kinetics of pORF59 expression, western blot
analysis was performed using lysates of cells infected with the
rAb4_59-HA virus harvested at different time points after infection
in the presence or absence of the viral DNA synthesis inhibitor
phosphonoacetic acid (PAA; Sigma). PAA was used at a concentra-
tion of 300 mg/ml and cells incubated in medium containing PAA
for 24 h (Ahn et al., 2011; Honess and Watson, 1977; Said et al.,
2012). Expression of β-actin and gM, was assessed to control
efﬁciency of PAA treatment. pORF59 expression was detected as
early as 1 h p.i. and was not affected by PAA treatment, while,
consistent with earlier results and as expected, expression of gM of
EHV-1 was virtually undetectable in the presence of PAA (Fig. 4A).
To further differentiate whether pORF59 is an immediate early (IE)
or early (E) protein, NBL6 cells were either mock-infected or
infected with parental or rAb4_59-HA virus in the presence of
the protein synthesis inhibitor cycloheximide (CX; Sigma) at a
concentration of 100 mg/ml medium (Ahn et al., 2011; Nataraj
et al., 1997). After 5 h, cells were washed and incubated with fresh
medium containing the transcription inhibitor actinomycin D (Act-
D; Sigma) at a concentration of 5 mg/ml. Lysates of cells were
analyzed after each treatment by western blotting. The results
showed that pORF59 was not detected after treatment of cells with
CX/Act-D (Fig. 4B) but was still expressed in the presence of PAA
(Fig. 4B). Overall, these ﬁndings suggested that the pORF59 is
expressed with early kinetics.
To address subcelluar localization of pORF59, NBL6 cells were
grown on coverslips and infected with either parental, rAb4_59-
HA or rAb4Δ59 viruses at a multiplicity of infection (m.o.i.) of 0.1.
At 18 h p.i., cells were ﬁxed for 15 min with 4% paraformaldehyde
in PBS and washed with PBS for 3 times, followed by 30 min
incubation with 0.1% saponin in PBS. After blocking with 2% bovine
serum albumin (BSA) in PBS for 1 h, ﬁxed cells were incubated
with anti-HA mouse MAb (1/500 in PBS-2%BSA) for 1 h at room
temperature (RT). Then, cells were incubated with secondary
Alexa Fluor 568 goat anti-mouse IgG (1/5000 in PBS–2%BSA) for
1 h at RT as described before (Ma et al., 2012; Parkinson et al.,
1999). Finally, after 3 washing steps, Vectashields medium with
DAPI (Vector Laboratories) was used to mount coverslips on slides
and cells were inspected under a Zeiss AxioImager M1 microscope
(Zeiss, Germany). The anti-HA MAb allowed us to localize pORF59
in the cytosol of cells infected with rAb4_59-HA (Fig. 5A), but no
speciﬁc reactivity was observed in cells infected with either
parental EHV-1 lacking the HA tag or the rAb4Δ59 mutant
(Fig. 5A). To further verify that pORF59 localized in cytosol of
infected cells, cytoplasmic and nuclear fractions were prepared
from infected NBL6 cells with rAb4_59-HA, exactly following a
procedure described before (Ahn et al., 2011; de Mendez et al.,
1994). Brieﬂy, NBL6 cells were infected with rAb4_59-HA and
washed at 24 h p.i. with ice-cold PBS. Cells were collected,
centrifuged and pellets resuspended in ice-cold buffer (10 mM
HEPES, pH 7.9; 10 mM MgCl2; 10 mM KCl; 0.5 mM DTT). The cells
were then centrifuged at 300g for 10 min at 4 1C to pellet the
nuclear fraction. The supernatant was kept as the cytoplasmic
fraction. The nuclear pellet was resuspended in sucrose buffer
(0.25 M sucrose, 10 mMMgCl2) and centrifuged at 3000g
for 20 min at 4 1C. Both fractions were subjected to analysis
by western blot and pORF59 detected using the anti-HA MAb.
The anti-HA MAb detected pORF59 in the cytosolic but not in the
nuclear fraction (Fig. 5B). Overall, our ﬁndings from immunoﬂuor-
escence analysis and fractionation studies strongly suggested an
exclusively cytoplasmic localization of pORF59.
To determine whether ORF59 is essential for growth of EHV-1
in vitro, we determined growth properties of the Ab4Δ59 virus.
For plaque size measurements, conﬂuent monolayers of NBL6 cells
were infected with mutant or parental virus, and plaque sizes
were determined as described previously (von Einem et al., 2007).
Brieﬂy, plaque areas were measured after infection at an m.o.i. of
0.001 of NBL6 cells seeded in a six-well plate and overlay with 1.5%
methylcellulose in IMDM/20% FBS at 1 h p.i. For each virus, 50
plaques were photographed at 3 days p.i. and mean plaque sizes
were analyzed using ImageJ software (http://rsb.info.nih.gov/ij/).
Plaque diameters of the rAb4Δ59 were compared with those of
parental and revertant viruses, which were set to 100%. Mean
percentages and SD were calculated from three independent
experiments. The results showed that the rAb4Δ59 was able to
grow on NBL6 cells monolayer with morphology and average
plaques sizes that were signiﬁcantly smaller when compared to
parental and revertant viruses and only consisted of only very few
cells (Fig. 6A and B). These ﬁndings suggest that the deletion of
Fig. 5. Localization of pORF59 in EHV-infected cells by immunoﬂuorescence and
western blot analysis: (A) immunoﬂuorescence was used to determine pORF59
localization in EHV-infected cells. NBL6 cells were infected with either parental
rAb4, rAb4_59-HA or rAb4Δ59 virus. Anti-HA MAb was used as a primary antibody
and Alexa Fluor 568 goat anti-mouse was used as a secondary antibody. Cells were
ﬁxed with 4% paraformaldehyde and permeabilized with 0.1% saponin in PBS.
Coverslips were mounted in a VECTASHIEDsmounting medium with DAPI (Vector
Laboratories) to stain nuclei. View: 40 , scale bar¼10 μm. (B) For cell fractiona-
tion, NBL6 cells were infected either with rAb4_59-HA or mock-infected. Identical
amounts of the cytoplasmic and nuclear fraction protein were separated in each
lane of SDS–polyacrylamide gels 12% and an anti-HA MAb was used for detection.
Lane 1 (M) shows molecular weight markers, lane 2 is a mock-infected cell, nuclear
fraction (lane 3) and cytoplasmic fraction (lane 4).
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ORF59 gene is required for efﬁcient growth of EHV-1 in cell
culture. This conclusion is corroborated by the fact that serial
passage of ORF59-negative viruses on NBL6 or RK13 cells was
impossible.
In this study, the protein product of the EHV-1 ORF59 was
analyzed. Positional homologs of ORF59 have been detected in
VZV (ORF57 (Cox et al., 1998), BHV-1 (UL3.5 (Schikora et al., 1998)),
EHV-4 (ORF59 (Telford et al., 1998)), and PRV (UL3.5 (Dean and
Cheung, 1993)). In contrast, in the members of the Simplexvirus
genus, including HSV-1 and HSV-2, no homolog is present
(McGeoch et al., 1988, 1991). Kinetic studies of EHV-1 pORF59
showed that expression starts as early at 1 h p.i. Consistent with
such an early appearance, pORF59 expression was not affected by
PAA treatment, indicating that pORF59 is a true early protein. In
contrast, treatment of BHV-1 infected cells with PAA showed that
BHV-1 UL3.5 was inhibited by the drug and thus was classiﬁed as a
late protein (Schikora et al., 1998). Because expression of pUL3.5 of
PRV was reduced but not eliminated in the presence of PAA, the
authors classiﬁed the PRV homolog as an early-late protein (Dean
and Cheung, 1993). The predicted molecular mass of EHV-1
pORF59, based on its amino acid sequence, is 19.8 kDa, which is
predicted to increase to 20.8 kDa by insertion of the epitope tag.
Immunoblot analysis of EHV-1 pORF59, including the inserted
epitope with an addition of 9 amino acids (YPYDVPDYA), detected
a protein with a molecular mass of approximately 21 kDa in
transfected and infected cells, which is in perfect agreement with
the prediction. Moreover, immunoﬂuorescence and fractionation
studies of infected cells using HA-tagged pORF59 in a viral back-
ground showed that the protein is located in the cytoplasm of
virus-infected cells. These ﬁndings are in agreement with previous
results for the VZV (Cox et al., 1998) and BHV-1 orthologues
(Schikora et al., 1998), which were reported to be also localized in
the cytosol of infected cells. It is worthwhile noting that the
homolog of EHV-1 ORF59 in VZV, ORF57, appears to not be
essential for virus growth as VZV unable to express ORF57
replicated to titers similar to those of parental virus. In contrast,
the UL3.5 protein of PRV was shown to play a major role in
secondary envelopment and for efﬁcient release of virions and
plaque formation. The absence of PRV UL3.5 could be comple-
mented by the BHV-1 orthologue, but the effects of an absence of
BHV-1 UL3.5 was never formally addressed (Fuchs et al., 1997).
In summary, we conclude that EHV-1 pORF59 (i) is a 21-kDa
protein expressed with early kinetics, (ii) localizes to the cytosol of
EHV-1-infected cells, and (iii) is essential for growth of EHV-1 in
cultured cells. Further experiments will be required to understand
the general role of ORF59 protein during EHV-1 virus maturation
and egress.
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